IRF7 is strongly hypomethylated in SARS-CoV-2 individuals, and IRF7 DNA methylation signatures may differentiate patients with SARS-CoV-2 infection from uninfected individuals and predict COVID-19 disease severity (145). This evidence concerns the gene IRF7 and COVID-19.